Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective

BACKGROUND: First-generation somatostatin receptor ligands (fg-SRLs) represent the first-line medical treatment for acromegaly, recommended in patients with persistent disease after neurosurgery, or when surgical approach is not feasible. Despite the lack of strong recommendations from guidelines an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nista, Federica, Corica, Giuliana, Castelletti, Lara, Khorrami, Keyvan, Campana, Claudia, Cocchiara, Francesco, Zoppoli, Gabriele, Prior, Alessandro, Rossi, Diego Criminelli, Zona, Gianluigi, Ferone, Diego, Gatto, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139627/
https://www.ncbi.nlm.nih.gov/pubmed/34025586
http://dx.doi.org/10.3389/fendo.2021.677919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139627/
https://www.ncbi.nlm.nih.gov/pubmed/34025586
http://dx.doi.org/10.3389/fendo.2021.677919

Ejemplares similares